Dr. Haber is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
MGH Cancer Center, Bldg 149, CNY-7, 13th Street
Boston, MA 02129Phone+1 617-726-7805Fax+1 617-724-6919- Is this information wrong?
Education & Training
Massachusetts Institute of TechnologyPost-Doctoral Fellowship, Center for Cancer Research, 1987 - 1991
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1986 - 1990
Massachusetts General HospitalResidency, Internal Medicine, 1984 - 1986- Massachusetts General HospitalInternship, Internal Medicine, 1983 - 1984
Stanford University School of MedicineClass of 1983
Certifications & Licensure
MA State Medical License 1985 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Elected Member Fellow of the AACR Academy, 2019
- Elected Member National Academy of Sciences, 2018
- Investigator Howard Hughes Medical Institute
- Join now to see all
Publications & Presentations
PubMed
- Circulating and Imaging Biomarkers of Radium-223 Response in Metastatic Castration-Resistant Prostate Cancer.Saylor, P., Otani, K., Balza, R., Ukleja, J., Pleskow, H., Fisher, R., Kusaka, E., Otani, Y., Badusi, P., Smith, M., Meneely, E., Olivier, K., Lowe, A., Toner, M., Mah...> ;JCO Precision Oncology. 2024 Feb 1
- Deploying blood-based cancer screening.Micalizzi, D., Sequist, L., Haber, D.> ;Science. 2024 Jan 26
- Germline mutations and developmental mosaicism underlying-mutant lung cancer.Risa Burr, Ignaty Leshchiner, Christina L Costantino, Martin Blohmer, Tilak Sundaresan, Justin Cha, Karsen Seeger, Sara Guay, Brian P Danysh, Ira Gore, Raquel A Jacobs...> ;Medrxiv. 2023 Sep 29
- Join now to see all
Journal Articles
- A Digital RNA Signature of Circulating Tumor Cells Predicting Early Therapeutic Response in Localized and Metastatic Breast CancerDavid T Miyamoto, Aditya Bardia, Lecia V Sequist, Laura M Spring, Daniel A Haber, Mark Kalinich, Clinical Cancer Research
Press Mentions
Isolation of Circulating Tumor Cells with TellDx Platform Reveals Potential Mechanism of Resistance to Immune Checkpoint Blockade in MelanomaMarch 16th, 2023- Reduction in Circulating Tumor Cells (CTC), Enriched by TellBio Platform, with Novel Dual-Cadherin Antibody (23C6) Results in Significant Metastasis SuppressionOctober 24th, 2022
- TellBio’s Scientific Founders Publish Very High Concordance Between CTCs and ctDNA from Liquid Biopsies in Patients with Breast CancerJuly 15th, 2021
- Join now to see all
Grant Support
- Circumventing Acquired Resistance To Growth Factor Receptor Kinase InhibitorsNational Cancer Institute2008–2012
- Data Production, And Informatics And IntegrationNational Human Genome Research Institute2010–2011
- P1 - Clinical Correlations Of WTX Inactivation In Wilms TumorNational Cancer Institute2010–2011
- Functional Properties Of The Wilms'Tumor Gene WT1National Cancer Institute2008–2011
- Functional Properties Of The Wilms' Tumor Gene WT1National Cancer Institute2010
- Clinical Correlations Of WTX Inactivation In Wilms TumorNational Cancer Institute2009
- Functional Properties Of The Wilm'S Tumor Gene WT1National Cancer Institute2003–2007
- Targets Of Ewing Sarcoma-Wilms Tumor 1 OncoproteinNational Cancer Institute2002–2006
- Genetic Models Of Cellular ProliferationNational Cancer Institute2002–2006
- Functional Characterization Of BRCA1National Cancer Institute2000–2004
- Screen For Genes Targeted By Homozygous Deletion During Cancer ProgressionNational Cancer Institute2002
- G2 Checkpoint Genes In Breast Cancer SusceptibiityNational Cancer Institute2000–2002
- Functional Properties Of The Wilms Tumor Gene WT1National Cancer Institute1998–2002
- Mutational Analysis Of P53 Related GenesNational Cancer Institute2000–2001
- Isolation Of Gene For X-Linked LymphoproliferationNational Cancer Institute1995–1998
- Mutational And Functional Analysis Of Wilm'S TumorNational Cancer Institute1994–1997
- Mutational And Functional Analysis Of Wilms'TumorNational Cancer Institute1993
- Multidrug Resistance Genes--Expression And FunctionNational Cancer Institute1990
- Multidrug Resistance Genes--Expression And FunctionNational Cancer Institute1988–1989
Hospital Affiliations
Massachusetts General HospitalBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
